Success Metrics

Clinical Success Rate
92.3%

Based on 12 completed trials

Completion Rate
92%(12/13)
Active Trials
18(40%)
Results Posted
0%(0 trials)
Terminated
1(2%)

Phase Distribution

Ph phase_1
1
2%
Ph phase_2
3
7%
Ph phase_3
2
4%
Ph not_applicable
18
40%

Phase Distribution

1

Early Stage

3

Mid Stage

2

Late Stage

Phase Distribution24 total trials
Phase 1Safety & dosage
1(4.2%)
Phase 2Efficacy & side effects
3(12.5%)
Phase 3Large-scale testing
2(8.3%)
N/ANon-phased studies
18(75.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

92.3%

12 of 13 finished

Non-Completion Rate

7.7%

1 ended early

Currently Active

18

trials recruiting

Total Trials

45

all time

Status Distribution
Active(22)
Completed(12)
Terminated(1)
Other(10)

Detailed Status

Recruiting17
Completed12
unknown9
Not yet recruiting4
Terminated1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
45
Active
18
Success Rate
92.3%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (4.2%)
Phase 23 (12.5%)
Phase 32 (8.3%)
N/A18 (75.0%)

Trials by Status

completed1227%
not_yet_recruiting49%
terminated12%
active_not_recruiting12%
recruiting1738%
suspended12%
unknown920%

Recent Activity

Clinical Trials (45)

Showing 20 of 45 trialsScroll for more
NCT06101667Not Applicable

Efficacy and Safety of Endovascular Recanalization for Acute Basilar Artery Occlusion With Extended Time Window (ANGEL-BAO)

Recruiting
NCT07263308Phase 3

Albumin for Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Therapy -2

Recruiting
NCT04141020Phase 2

Effect of Sirolimus on Molecular Alterations in Cerebral Aneurysms

Recruiting
NCT04698304

The Efficacy of Endovascular Treatment in FPOD With TASC C and D Lesions

Active Not Recruiting
NCT07323368Not Applicable

Advancing Reperfusion Therapy for Ischemic Stroke: Perfusion-guided Endovascular Intervention for Medium Vessel Occlusion Therapy

Recruiting
NCT07336927Not Applicable

IAT-MeVO Trial Domain Within the ACT-GLOBAL Adaptive Platform Trial

Not Yet Recruiting
NCT07315633

An Innovative CFD-based Dosimetry and Pre-treatment Planning Platform to Support Personalized Transarterial Therapies for Liver Cancer

Recruiting
NCT05631847Not Applicable

Direct Endovascular Treatment Versus Bridging Treatment In Basilar Artery Occlusive Stroke

Completed
NCT04861506

The Safety and Efficiency of Endovascular Treatment of Acute or Subacute Thromboembolic Occlusions of Lower Extremity.

Recruiting
NCT06016348

PROMISE: PRedictors Of Good outcoMes in Thrombectomy for Large Infarct Core Stroke Evaluation

Completed
NCT06383182

Change in Serum Biomarkers After Endovascular Treatment for Acute Anterior Circulation Large Vessel Occlusion

Recruiting
NCT07090941Not Applicable

EVT in Acute Basilar Artery Occlusion With Large Infarction Core

Recruiting
NCT07016854Not Applicable

Early Endovascular Treatment in Isolated Internal Carotid Artery Occlusion

Recruiting
NCT06959199Not Applicable

Endovascular Treatment Beyond 24 Hours for Acute Ischemic Stroke Caused by Anterior Circulation Large Vessel Stenosis

Recruiting
NCT02748226

Korean Vascular Intervention Society Multicenter Registry Study on Outcomes of Endovascular Therapy in Lower Limb Artery Diseases (K-VIS ELLA): (A Retrospective & Prospective Observational Study)

Recruiting
NCT06843356Not Applicable

Trial of Rescue Endovascular Treatment for Progressive Acute Mild Ischemic Stroke With Basilar Artery Occlusion With Extended Time Window

Recruiting
NCT04733742Phase 2

Endovascular Treatment With Versus Without Intravenous rhTNK-tPA in Stroke

Completed
NCT06899399Not Applicable

Efficacy and Safety Study of Endovascular Treatment of Asymptomatic Carotid Artery Stenosis

Recruiting
NCT05092139

Endovascular treatmenT for Acute Ischemic Stroke in China (DETECT2-China)

Completed
NCT05864638

Acute Ischemic Stroke EndoVascular Therapy: a Multicenter REGISTRY Study

Recruiting

Drug Details

Intervention Type
PROCEDURE
Total Trials
45